Dr. Balmanoukian on Immunotherapy Advancements in GU Cancers – OncLive
OncLive |
Dr. Balmanoukian on Immunotherapy Advancements in GU Cancers
OncLive Ani Balmanoukian, MD, director of Thoracic Oncology, associate director of the Phase I Immune-Oncology Program, The Angeles Clinic and Research Institute, discusses immunotherapy advancements in genitourinary (GU) cancers. The field has come a long way … |
